Atherosclerosis: Low-dose aspirin failed to improve cardiovascular outcomes

Nature Reviews Cardiology

Volumn 12, Issue 1, 2015, Pages 3-

  Huynh, Karina ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; DRUG TREATMENT FAILURE; HEART INFARCTION; HUMAN; LOW DRUG DOSE; NOTE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; CARDIOVASCULAR DISEASES; FEMALE; MALE; MYOCARDIAL INFARCTION;

ASPIRIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS;

EID: 84926647948     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2014.194     Document Type: Note

References (2)

1. Ikeda, Y. et al. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: A randomized clinical trial. JAMA doi:10.1001/jama.2014.15690
2. Gaziano, J. M. & Greenland, P. When should aspirin be used for prevention of cardiovascular events. JAMA doi:10.1001/jama.2014.16047